Related content

Targeted Therapies in the Treatment of Advanced Renal Cell Carcinoma

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 4, Iss. 2, 2009-06 ,pp. : 146-156

Bentham Science Publishers

Access to resources Recommend Favorite

Feasibility and activity for sequencing targeted therapies for the treatment of advanced renal cell carcinoma

By Procopio Giuseppe  

Medical Oncology, Vol. 27, Iss. 4, 2010-12 ,pp. : 1267-1268

Humana Press, Inc

Access to resources Recommend Favorite

MG98, a Second-Generation DNMT1 Inhibitor, in the Treatment of Advanced Renal Cell Carcinoma

By Amato Robert J.   Stephenson Joe   Hotte Sebastien   Nemunaitis John   Bélanger Karl   Reid Gregory   Martell Robert E.  

Cancer Investigation, Vol. 30, Iss. 5, 2012-05 ,pp. : 415-421

Informa Healthcare

Access to resources Recommend Favorite

Patient approach in advanced/metastatic renal cell carcinoma: focus on the elderly population and treatment-related toxicity

By Verzoni Elena   de Braud Filippo   Fabiani Francesca   Grassi Paolo   Testa Isabella   Procopio Giuseppe  

Future Oncology, Vol. 9, Iss. 11, 2013-11 ,pp. : 1599-1607

Future Medicine

Access to resources Recommend Favorite

Update from the Spanish Oncology Genitourinary Group on the treatment of advanced renal cell carcinoma: focus on special populations

By Calvo Emiliano   Maroto Pablo   Muro Xavier   Climent Miguel   González-Larriba José   Esteban Emilio   López Rafael   Paz-Ares Luis   Bellmunt Joaquim   Castellano Daniel  

Cancer and Metastasis Reviews, Vol. 29, Iss. 1, 2010-08 ,pp. : 11-20

Springer Publishing Company

Access to resources Recommend Favorite